Authors:
JENSEN PD
OLSEN N
BAGGER JP
JENSEN FT
CHRISTENSEN T
ELLEGAARD J
Citation: Pd. Jensen et al., CARDIAC-FUNCTION DURING IRON CHELATION-THERAPY IN ADULT NON-THALASSEMIC PATIENTS WITH TRANSFUSIONAL IRON OVERLOAD, European journal of haematology, 59(4), 1997, pp. 221-230
Authors:
BERGMANN OJ
MOGENSEN SC
ELLERMANNERIKSEN S
ELLEGAARD J
Citation: Oj. Bergmann et al., ACYCLOVIR PROPHYLAXIS AND FEVER DURING REMISSION-INDUCTION THERAPY OFPATIENTS WITH ACUTE MYELOID-LEUKEMIA - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, Journal of clinical oncology, 15(6), 1997, pp. 2269-2274
Authors:
GEISLER CH
PHILIP P
CHRISTENSEN BE
HOUJENSEN K
PEDERSEN NT
JENSEN OM
THORLING K
ANDERSEN E
BIRGENS HS
DRIVSHOLM A
ELLEGAARD J
LARSEN JK
PLESNER T
BROWN P
ANDERSEN PK
HANSEN MM
Citation: Ch. Geisler et al., IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA CHROMOSOME-17 ABNORMALITIES AND NOT TRISOMY-12 ARE THE SINGLE MOST IMPORTANT CYTOGENETIC ABNORMALITIES FOR THE PROGNOSIS - A CYTOGENETIC AND IMMUNOPHENOTYPIC STUDY OF 480UNSELECTED NEWLY-DIAGNOSED PATIENTS, Leukemia research, 21(11-12), 1997, pp. 1011-1023
Authors:
GEISLER CH
HANSEN MM
PHILIP P
CHRISTENSEN BE
HOUJENSEN K
TINGGAARDPEDERSEN N
JENSEN OM
THORLING K
ANDERSEN E
HANSEN NE
NIELSEN H
NIELSEN JB
ELLEGAARD J
LARSEN JK
BROWN P
ANDERSEN PK
Citation: Ch. Geisler et al., IN B-CLL, CHLORAMBUCIL AND CHOP GIVE EQUAL SURVIVAL AND CHROMOSOME-17ABNORMALITIES IS THE SINGLE MOST IMPORTANT FACTOR FOR THE OUTCOME OF TREATMENT - A CYTOGENETIC, IMMUNOPHENOTYPIC AND BONE-MARROW HISTOLOGICAL STUDY OF 175 CONSECUTIVE NEWLY-DIAGNOSED PATIENTS RANDOMIZED TO EITHER CHOP OR CHLORAMBUCIL PLUS PREDNISOLONE, Blood, 90(10), 1997, pp. 2358-2358
Authors:
JENSEN PD
HEICKENDORFF L
PEDERSEN B
BENDIXHANSEN K
JENSEN FT
CHRISTENSEN T
BOESEN AM
ELLEGAARD J
Citation: Pd. Jensen et al., THE EFFECT OF IRON CHELATION ON HEMATOPOIESIS IN MDS PATIENTS WITH TRANSFUSIONAL IRON OVERLOAD, British Journal of Haematology, 94(2), 1996, pp. 288-299
Authors:
GEISLER CH
PHILIP P
CHRISTENSEN BE
HOUJENSEN K
PEDERSEN NT
JENSEN OM
THORLING K
ANDERSEN E
HANSEN NE
NIELSEN H
ELLEGAARD J
LARSEN JK
BROWN P
ANDERSEN PK
HANSEN MM
Citation: Ch. Geisler et al., TRISOMY-12 IS FOUND IN CLL WITH BOTH TYPICAL AND ATYPICAL IMMUNOPHENOTYPE AND HAS NO PROGNOSTIC-SIGNIFICANCE - A CYTOGENETIC AND IMMUNOPHENOTYPIC STUDY OF 480 UNSELECTED NEWLY-DIAGNOSED PATIENTS, Blood, 88(10), 1996, pp. 937-937
Authors:
DYBKAER K
ELLEGAARD J
PEDERSEN B
KRISTENSEN JS
Citation: K. Dybkaer et al., CLINICAL AND BIOLOGICAL ASPECTS OF MYELOID SURFACE-ANTIGEN EXPRESSIONIN ACUTE MYELOID-LEUKEMIA AND MYELODYSPLASTIC SYNDROME, Tissue antigens, 48(4-II), 1996, pp. 611-611
Authors:
BERGMANN OJ
ELLERMANNERIKSEN S
MOGENSEN SC
ELLEGAARD J
Citation: Oj. Bergmann et al., ACYCLOVIR GIVEN AS PROPHYLAXIS AGAINST ORAL ULCERS IN ACUTE MYELOID-LEUKEMIA - RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, BMJ. British medical journal, 310(6988), 1995, pp. 1169-1172
Authors:
JENSEN PD
JENSEN FT
CHRISTENSEN T
ELLEGAARD J
Citation: Pd. Jensen et al., EVALUATION OF TRANSFUSIONAL IRON OVERLOAD BEFORE AND DURING IRON CHELATION BY MAGNETIC-RESONANCE-IMAGING OF THE LIVER AND DETERMINATION OF SERUM FERRITIN IN ADULT NON-THALASSEMIC PATIENTS, British Journal of Haematology, 89(4), 1995, pp. 880-889
Authors:
MADSEN PS
HOKLAND P
CLAUSEN N
ELLEGAARD J
HOKLAND M
Citation: Ps. Madsen et al., DIFFERENTIAL EXPRESSION LEVELS OF THE HEAT-SHOCK PROTEIN-27 ISOFORMS IN PEDIATRIC NORMAL, NONLEUKEMIC AND COMMON ACUTE LYMPHOBLASTIC-LEUKEMIA B-CELL PRECURSORS, Blood, 85(2), 1995, pp. 510-521
Citation: B. Pedersen et J. Ellegaard, A FACTOR ENCODED BY 7Q31 SUPPRESSES EXPANSION OF THE 7Q- CLONE AND DELAYS CYTOGENETIC PROGRESSION, Cancer genetics and cytogenetics, 78(2), 1994, pp. 181-188
Authors:
JENSEN PD
PETERSLUND NA
POULSEN JH
JENSEN FT
CHRISTENSEN T
ELLEGAARD J
Citation: Pd. Jensen et al., THE EFFECT OF IRON OVERLOAD AND IRON REDUCTIVE TREATMENT ON THE SERUMCONCENTRATION OF CARBOHYDRATE-DEFICIENT TRANSFERRIN, British Journal of Haematology, 88(1), 1994, pp. 56-63
Citation: Pd. Jensen et al., NONINVASIVE ASSESSMENT OF TISSUE IRON OVERLOAD IN THE LIVER BY MAGNETIC-RESONANCE-IMAGING, British Journal of Haematology, 87(1), 1994, pp. 171-184
Authors:
JENSEN IM
KRISTENSEN JS
THOMSEN M
ELLEGAARD J
HOKLAND P
Citation: Im. Jensen et al., OPTIMIZATION OF A METHOD FOR SIMULTANEOUS ANALYSIS OF CELL-SURFACE PHENOTYPE AND CELL-CYCLE IN HUMAN BONE-MARROW AND PERIPHERAL-BLOOD LEUKOCYTES BY FLOW-CYTOMETRY - THE VALUE OF BOTH INTERNAL AND EXTERNAL STANDARDS, Analytical cellular pathology, 5(4), 1993, pp. 213-223
Authors:
JENSEN PD
BAGGER JP
BAANDRUP U
CHRISTENSEN T
ELLEGAARD J
JENSEN FT
Citation: Pd. Jensen et al., HEART-TRANSPLANTATION IN A CASE OF JUVENILE HEREDITARY HEMOCHROMATOSIS FOLLOWED UP BY MRI AND ENDOMYOCARDIAL BIOPSIES, European journal of haematology, 51(4), 1993, pp. 199-205
Authors:
KELDSEN N
BJERRUM OW
DAHL IMS
DRIVSHOLM A
ELLEGAARD J
GADEBERG O
GIMSING P
GRONVOLD T
HANSEN MM
HIPPE E
LAMVIK J
LY B
SKARBOVIK A
TALSTAD I
THORLING K
WESENBERG K
WISLOFF F
Citation: N. Keldsen et al., MULTIPLE-MYELOMA TREATED WITH MITOXANTRONE IN COMBINATION WITH VINCRISTINE AND PREDNISOLONE (NOP REGIMEN) VERSUS MELPHALAN AND PREDNISOLONE- A PHASE-III STUDY, European journal of haematology, 51(2), 1993, pp. 80-85
Citation: Im. Jensen et al., DIFFERENCES IN RELATIVE DNA CONTENT BETWEEN HUMAN PERIPHERAL-BLOOD AND BONE-MARROW SUBPOPULATIONS - CONSEQUENCES FOR DNA INDEX CALCULATIONS, Cytometry, 14(8), 1993, pp. 936-942
Authors:
NORGAARD JM
LANGKJER ST
ELLEGAARD J
PALSHOF T
CLAUSEN N
HOKLAND P
Citation: Jm. Norgaard et al., SYNERGISTIC AND ANTAGONISTIC EFFECTS OF MYELOID GROWTH-FACTORS ON IN-VITRO CELLULAR KILLING BY CYTOTOXIC DRUGS, Leukemia research, 17(8), 1993, pp. 689-694
Authors:
KRISTENSEN J
KILLANDER A
HIPPE E
ELLEGAARD J
HEDNER U
Citation: J. Kristensen et al., RECOMBINANT FACTOR-VIIA (RFVIIA) REDUCES THE BLEEDING-TIME IN PATIENTS WITH THROMBOCYTOPENIA, Blood, 82(10), 1993, pp. 10000155-10000155